Cillo, Vebencia M.
HRN: 00-48-41 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2023
METRONIDAZOLE 500MG (TAB)
09/17/2023
09/23/2023
PO
500MG
TID
Amoebiasis
Checking Final Appropriateness
09/18/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/18/2023
09/25/2023
IV
500mg
Q8H
Intestinal Amoebiasis
Checking Final Appropriateness